Abstract
The use of surfactants as emulsifying agents, solubilizers, suspension stabilizers and as wetting agents in formulations intended for administration to human subjects or to animals can lead to significant changes in the biological activity of the active agent in the formulation. A drug is seldom administered as such but as a complex formulation. Surfactant molecules incorporated into the formulation can exert their multifarious effects in several ways, e.g. by influencing the deaggregation and dissolution of solid dose forms (Fig. 7.1), by controlling the rate of precipitation of drugs administered in solution form, by increasing membrane permeability and affecting membrane integrity. Complex interactions occur between surfactants and proteins and thus there is the possibility of a surfactant-induced alteration of drug metabolizing enzyme activity. There has also been the suggestion that surfactants may influence the binding of the drug to the receptor site. The determinants of the effectiveness of surfactants on drug absorption are several. Drugs in which dissolution and not membrane transport is the rate-limiting step in absorption and drugs in which the latter is the rate- determining step may be affected differently. Water-soluble drugs will not and water-insoluble drugs will interact with surfactant micelles thus high concentrations of surfactants are likely to affect lipophilic and hydrophobic drugs to differing degrees. Some surfactants have direct physiological activity of their own and in the intact animal can thus affect the physiological environment, e.g. by altering gastric residence time such that without physico-chemical intervention, a surfactant-effect will be seen.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
O. Blanpin (1958) Prod. Pharm. 13, 425.
G. Billard and L. Dieulafe (1904) Compt. Rend. Soc. Biol. 56, 146.
G. Levy and S. P. Gucinski (1964) J. Pharmac. exp. Therap. 146, 80.
G. Levy, K. E. Miller and R. H. Reuning (1966) J. Pharm. Sci. 55 , 394.
G. Levy and J. A. Anello (1968) J. Pharm. Sci. 57, 101.
I. Moran, J. Gillard and M. Roland (1971) J. Pharm. Belg. 26, 115.
S. Schrang and P. Finholt (1970) Meddr. norsk farm Selsk. 31, 101.
M. P. Short, P. Sharkey and C. T. Rhodes (1972) J. Pharm. Sci. 61, 1732.
L. S. C. Wan (1972) canad. J. Pharm. Sci. 7, 25.
J. A. Rees and J. H. Collett (1974) J. Pharm. Pharmacol. 26, 956.
E. Cid and F. Jaminet (1971) J. Pharm. Belg. 26, 369.
P. Finholt and S. Solvang (1968) J. Pharm. Sci. 57, 1322.
G. Levy and R. H. Gumtow (1963) J. Pharm. Sci. 52, 1139.
L. Prescott, R. F. Steel and W. R. Ferrier (1970) Clin. Pharmacol. Therap. 11, 496.
R. K. Reddy, S. A. Khalil and M. W. Gouda (1976) J. Pharm. Sci. 65, 1753.
R. K. Reddy,S. A. Khalil and M. W. Gouda (1976) J. Pharm. Sci. 65, 115.
B. R. Hajratwala and H. Taylor (1976) J. Pharm. Pharmacol. 28, 934.
K. J. Mysels and A. T. Florence (1970) in Clean Surfaces (ed. G. Goldfinger) Marcel Dekker, New York. pp. 227ff.
J. H. Collett and J. A. Rees (1975) J. Pharm. Pharmacol. 27, 647.
E. L. Parrott and V. K. Sharma (1967) J. Pharm. Sci. 56, 1341.
P. H. Elworthy and F. J. Lipscomb (1968) J. Pharm. Pharmacol. 20, 923.
W. I. Higuchi (1964) J. Pharm. Sci. 53, 532.
N. Watari and N. Kaneniwa (1976) Chem. Pharm. Bull. 24, 2577.
W. I. Higuchi (1967) J. Pharm. Sci. 56, 315.
M. Gibaldi, S. Feldman and N. D. Weiner (1970) Chem. Pharm. Bull. 18, 715.
P. V. Danckwerts (1951) Industr. Eng. Chem. 43, 1460.
H. L. Toor and J. M. Marchello (1958) A. I. Chem. E. J. 4, 97.
P. H. Elworthy and F. J. Lipscomb (1968) J. Pharm. Pharmacol. 20, 923.
P. H. Elworthy and F. J. Lipscomb (1969) J. Pharm. Pharmacol. 21, 273.
W. E. Hamlin, E. Nelson, B. E. Ballard and J. G. Wagner (1962) J. Pharm. Sci. 51, 432.
A. F. Chan, D. F. Evans and E. L. Cussler (1976) A. I. Chem. E. J. 22, 1006.
P. Somasundaran, T. W. Healy and D. W. Fuerstenau (1966) J. Colloid Interface Sci. 22, 599.
J. L. Ford and M. H. Rubinstein (1978) J. Pharm. Pharmacol. 30, 512.
A. Hoelgaard and N. Møller (1975) Arch. Pharm., Chemi. Sci. Ed. 3, 65.
A. Hoelgaard and N. Møller (1975) Arch. Pharm., Chemi. Sci. Ed. 3, 34.
W. L. Chiou, S-J. Chen and N. Athanikar (1976) J. Pharm. Sci. 65, 1702.
A. S. Michaels and A. R. Colville (1960) J. Phys. Chem. 64, 13.
A. S. Michaels, P. L. T. Brian and W. F. Beck (1967) Proc. 4th Int. Conf. Surface Active Agents (1964) 2, 1053.
G. Levy, K. E. Miller and R. H. Reuning (1966) J. Pharm. Sci. 55, 394.
A. T. Florence and J. M. N. Gillan (1975) J. Pharm. Pharmacol. 27, 152.
A. T. Florence and J. M. N Gillan (1975) Pesticide Sci. 6, 429.
A. T. Florence (1977) in Micellization, Solubilization and Microemulsions (ed. K. L. Mittal) vol. 1, plenum press, new york, pp. 55–74.
A. T. Florence (1981) in Techniques of Solubilization of Drugs (ed. S. Yalkowsky) Marcel Dekker, New York.
K. A. Walters, P. H. Dugard and A. T. Florence (1981) J. Pharm. Pharmacol. 33, 207.
K. A. Walters, A. T. Florence and P. H. Dugard (1982) int. J. Pharmaceutics 10,153.
L. W. Smith, C. L. Foy and D. E. Bayer (1966) Weed Research 6, 233.
A. Kaneda, K Nishimura, S. Muranishi and H. Sezaki (1974) Chem. Pharm. Bull. 22, 523.
D. A. Whitmore, L. G. Brookes and K. P. Wheeler (1979) J. Pharm. Pharmacol. 31, 277.
J. A. Nissim (1960) Nature 187, 308.
E. Cid (1971) Pharm. Acta. Helv. 46, 377.
B. Isomaa and G. Sjoblöm (1975) Fd. Cosmet. Toxicol. 13, 517.
W. D. Seufert (1965) Nature 207, 174.
K. A. Walters, A. T. Florence and P. H. Dugard (1982) J. Colloid Interface Sci. In press.
P. Seeman (1966) Biochem. Pharmacol. 15, 1737.
P. Seeman (1969) Biochim. Biophys. Acta 183, 490.
P. D. Swanson, H. F. Bradford and H. Mcilwain (1964) Biochem J. 92, 235.
H. F. Bradford, P. D. Swanson and D. B. Gammack (1964) Biochem J. 92, 247.
S. Kitazawa, M. Ishizu and K. Kimura (1977) Chem. Pharm. Bull. 25, 590.
R. Withington and J. H. Collett (1973) J. Pharm. Pharmacol. 25, 273.
H. Matsumoto, H. Matsumura and S. Iguchi (1966) Chem. Pharm. Bull. 14, 385.
K. Juni, T. Tomitsuka, M. Nakano and T. Arita (1978) Chem. Pharm. Bull. 26, 837.
J. H. Collett, R. Withington and B. Cox (1974) J. Pharm. Pharmacol. 26, 34.
J. H. Collett and R. Withington (1973) J. Pharm. Pharmacol. 25, 723.
A. H. Hikal, L. Dyer and S. W. Wong (1976) J. Pharm. Sci. 65, 621.
A. Brodin (1975) Acta. Pharm. Suec. 12, 41.
F. H. Garner and A. R. Hale (1953) Chem. Engn. Sci. 2, 157.
M. E. Kitler and P. Lamy (1971) Pharm. Acta. Helv. 46, 483.
P. H Elworthy (1959) J. Chem. Soc. 813 and 1951.
P. H. Elworthy and D. S. Mcintosh (1964) J. Phys. Chem. 68, 3448.
J. H. Collett and L. Koo (1975) Acta. Pharm. Suec. 12, 81.
A. A. El-Sayed and M S Mohammed (1976) Bull. Fac Pharm., Cairo University 15, 217.
G. Levy and T. Matsuzawa (1965) J. Pharm. Sci. 54, 1003.
G Levy, K. E. Miller and R H. Reuning (1966) J. Pharm. Sci. 55, 394.
E. R M. Kay (1965) Cancer Res. 25, 764.
K. Kakemi, T. Arita and S. Muranishi (1965) Chem. Pharm. Bull. 13, 976.
K. J Mysels (1969) Adv. Chem. Ser. 86, 24.
K. Kakemi, T. Arita, H. Sezaki and I. Sugimoto (1964) Yakugaku Zasshi 84, 1210.
D. C. Bloedow and W. L. Hayton (1976) J. Pharm. Sci. 65, 334.
D. C. Bloedow and W. L. Hayton (1976) J. Pharm. Sci. 65, 328.
K. Thomas, G. Pfaff and K. Quiring (1978) J. Pharm. Pharmacol. 30, 270.
B L. Oser and M. Oser (1957) J. Nutr. 61, 149.
P. J. Culver, C. S. Wilcox, C. M. Jones and R. S. Rose (1951) J. Pharmacol. Exp. Therap. 103, 377.
M. N. Azmin, A. T. Florence, J. F. B. Stuart and T. L. Whateley (1982) J. Pharm. Pharmacol. 36.
W. W. Davis, R. R. Pfeiffer and J. F. Quay (1970) J. Pharm. Sci. 59, 960.
W. W. Davis and C. J Kreutler (1971) J. Pharm. Sci. 60, 1651.
C. J. Kreutler and W. W. Davis (1971) J. Pharm. Sci. 60, 1835.
D. P. Sanvordeker and J. Bloss (1977) J. Pharm. Sci. 66, 82.
E. Touitou, M. Donbrow and A. Rubinstein (1978) J. Pharm. Pharmacol. 32, 108.
M. Schichiri, R. Kawamori et al. (1978) Acta Diabetologica Latina 15, 175.
R. W. Wissler, W. F. Bethard, P. Barker and H. D. Mori (1954) Proc. Soc. Exp. Biol. Med. 86, 170.
J. Soejima (1955) Wagasaki Igakki kassi 30, 219 [CA 49, 10524C ).
V. Kozlik and B. Mosinger (1956) Die Pharmazie 11, 22.
J. Nissim (1960) Nature 187, 308.
P. M. Lish and J. H. Weikel (1959) Toxicol Appl. Pharmacol. 1, 501.
A. Albert (1979) Selective Toxicity 6th edn, Chapman and Hall, London.
A. F. Hofmann (1965) Gastroenterology 48, 484.
T. R. Bates, M. Gibaldi and J. L. Kanig (1966) J. Pharm. Sci. 55, 191.
T. R. Bates, M. Gibaldi and J. L. Kanig (1966) Nature 210, 1331.
M. H. Malone, H. I. Hochman and K. A. Nieforth (1966) J. Pharm. Sci. 55, 972.
J. L. Lach and W. A. Pauli (1966) J. Pharm. Sci. 55, 32.
British Patent 378, 935 (1931).
Swiss Patents 126, 502; 130, 091–3 (1948).
U. P. Basu, S. Mukherjee and R. P. Banerjee (1947) J. Amer. Pharm. Assoc. 36, 266.
J. Amer. Med. Assoc. (1945) 128, 495.
T. R. Bates, M. Gibaldi and J. L. Kanig (1966) J. Pharm. Sci. 55, 901.
C. Marriott and I. W. Kellaway (1976) J. Pharm. Pharmacol. 28, 620.
M. Gibaldi and C. H. Nightingale (1968) J. Pharm. Sci. 57, 1354.
C. H. Nightingale, R. J. Wynn and M. Gibaldi (1969) J. Pharm. Sci. 58, 1005.
K. Inui, M. Shintomi, R. Hori and H. Sezaki (1976) Chem. Pharm. Bull. 24, 2504.
S. Feldman and M. Gibaldi (1969) Proc. Soc. Exp. Biol. Med. 132, 1031.
S. Muranishi, N. Muranishi and H. Sezaki (1979) Int. J. Pharmaceutics 2, 101.
R. Hori, K. Okumura, K. Inui, N. Nakamura, A. Miyoshi and T. Suyama (1977) Chem. Pharm. Bull. 25, 1974.
T. Kimura, k. Inui and H. Sezaki (1971) yakuzaigaku 31, 167.
K. Kakemi, H. Sezaki, R. Konishi, T. Kimuraand A. Okita (1970) Chem. Pharm. Bull. 18, 1034.
S. Feldman and M. Gibaldi (1969) J. Pharm. Sci. 58, 425.
J. M. Dietschy (1968) J. Lipid Res. 9, 297.
E. G. Lovering and D. B. Black (1974) J. Pharm. Sci. 63, 671.
K. Taniguchi, S. Muranishi and H. Sezaki (1980) Int. J. Pharmaceutics 4, 219.
I. Utsumi, K. Kohno and Y. Takeuchi (1974) J. Pharm. Sci. 63, 676.
I. Utsumi, K. Kohno and Y. Takeuchi (1973) Chem. Pharm. Bull. 21, 1727.
S. Miyazaki, T. Yamahira, H. Inoue and T. Nadai (1980) Chem. Pharm. Bull. 28, 323.
K. Kakemi, T. Arita and S. Muranishi (1965) Chem. Pharm. Bull. 13, 861.
K. Kakemi, H. Sezaki, S. Muranishi and Y. Tsujimura (1969) Chem. Pharm. Bull. 17, 1650.
E. Suzuki, M. Tsukigi, S. Muranishi, H. Sezaki and K. Kakemi (1972) J. Pharm. Pharmacol. 24, 138.
G. Fiese and J. H. Perrin (1969) J. Pharm. Sci. 58, 599.
R. M. Patel and G. Zografi (1966) J. Pharm. Sci.
J. T. Doluisio, W. G. Crouthamel, G. H. Tan, J. V. Swintosky and L. W. Dittert (1970) J. Pharm. Sci. 59, 72.
Y. Yamasaki, M. Schichiri, R. Kawamori, Y. Shigeta and H. Abe (1978) Diabetes 27, suppl. 2, 514.
K. Ichikawa, I. Ohata, M. Mitomi, B. Kawamura, H. Maeno and H. Kawata (1980) J. Pharm. Pharmacol. 32, 314.
E. Touitou, M. Donbrow and E. Azaz (1978) J. Pharm. Pharmacol. 30, 662.
T. Matsuzawa, H. Fujisawa, K. Aoki and H. Mima (1969) Chem. Pharm. Bull. 17, 999.
H. Kobayashi, T. Nishimura, K. Okumura, S Muranishi and H. Sezaki (1974) J. Pharm. Sci. 63, 580.
H. Kobayashi, T. Peng, M. Fujikawa, S. Muranishi and H. Sezaki (1976) Chem. Pharm. Bull. 24, 2383.
H. Kobayashi, T. Peng, R. Kawamura, S. Muranishi and H. Sezaki (1977) Chem. Pharm. Bull. 25, 569.
R. Scheuplein (1978) in The Physiology and Pathophysiology of the Skin, (ed. A. Jarrett) Vol. 5, Academic Press, London.
P. H. Dugard and R. J. Scheuplein (1973) J. Inert. Derm. 60, 263.
R. J. Scheuplein and L. Ross (1970) J. Soc. Cosmetic chem. 21, 853.
J. A. Faucher, E. D. Goddardand, R. D.Kulkarni (1979)J. Amer. Oil. Chem. Soc. 56, 776.
R. L. Goldemberg and L. Safrin (1977) J. Soc. Cosmet. Chem. 28, 667.
R. T. Yousef and M. N. Khawam (1966) Archiv, für Mikrobiologie 53, 159.
B. J. Poulsen (1973) in Drug Design (ed. A. J. Ariens) Vol. 4, Academic Press, New York, p. 149.
B. Levy and C. L. Huyck (1949) J. Amer. Pharm. Assoc. Sci. Ed. 38, 611.
W. Saski and S. G. Shah (1965) J. Pharm. Sci. 54, 277.
L. H. Macdonald and R. E. Himelick (1948) J. Amer. Pharm. Assoc., Sci. Ed. 37, 368.
K. J. Ryan and M. Mezei (1975) J. Pharm. Sci. 64, 671.
M. Mezei, R. W. Sager, W. D. Stewart and A. L. de Ruyter (1966) J. Pharm. Sci. 55, 584.
Z. T. Chowhan and R. Pritchard (1978) J. Pharm. Sci. 67, 1272.
R. J. Scheuplein and I. H. Blank (1971) Physiol. Rev. 51, 202.
W. W. Shen, A. G. Danti and F. N. Bruscato (1976) J. Pharm. Sci. 65, 1780.
M. Tanaka, N. Yanagibashi, H. Fukuda and T. Nagai (1980) Chem. Pharm. Bull. 28, 1056.
J. S. Turi, D. Danielson and J. W. Woltersorn (1979) J. Pharm. Sci. 68, 275.
B. Garcia, J. P. Marty and J. Wepierre (1980) Int. J. Pharmaceutics 4, 205.
E. Cid (1968) II Farmaco. Ed. Rrat. 23, 474.
G. Åberg and G. Adler (1976) Arzneimittel Forsch. 26, 78.
R. J. Marsh and D. M. Maurice (1971) Exp. Eye. Res. 11, 43.
C. S. O’Brien and K. C. Swan (1942) AMA, Arch. Ophthalmol. 27, 253.
I. H. Leopold and H. G. Scheie (1943) AMA, Arch. Ophthalmol. 29, 811.
J. G. Bellows and M. Gutmann (1943) AMA, Arch. Ophthalmol. 30, 352.
M. Ginsburg and J. M. Robson (1945) Brit. J. Ophthalmol. 29, 185.
M. Ginsburg and J. M. Robson (1949) Brit. J. Ophthalmol. 33, 574.
L. Von Sallmann and K. Meyer (1944) AMA, Arch. Ophthalmol. 31, 1.
K. A. Reiser (1952) Klin. Monatsb. Augenheik 121, 257.
H. Fujino (1953) Acta Soc. Ophthalmol. Jap. 57, 1347.
L. W. Hagleton (1952) Proc. Sci. Sect. Toilet Goods Ass. 17, 5.
T. Yamada, Y. Iwanawa and T. Baba (1963) Gann 54, 171.
S. H. Roth and P. J. Williams (1979) J. Pharm. Pharmacol. 31, 224.
J. P. Davignon, H. B. Wood and J. C. Craddock (1973) Cancer Chemotherapy Reports. 4, 7.
M. Nicolou, A. J. Lapa and J. R. Valle (1978) Arch. Int. Pharmacodyn. 236, 131.
L. A. Borgen and W. M. Davis (1973) J. Pharm. Sci. 62, 479.
R. D. Sofia, R. K. Kubena and H. Barry (1974) J. Pharm. Sci. 63, 939.
M. A. K. Mattila, M. Ruoppi, M. Korhonen, H. M. Larni, L. Valtomen and H. Heikkinen (1979) Br. J. Anaesth. 51, 891.
J. Kanto (1974) Brit. J. Anaesthesia 46, 817.
E. Ullmann (1961) Proceedings of the XXI International Pharmaceutical Congress, Pisa.
E. Ullmann and B. Moser (1962) Arch. Pharm. 295, 136.
R. J. Dubos and B. D. Davis (1946) J. Expt. Med. 83, 409.
H. S. Forrest, P. D’Arcy Hart and J. Walker (1947) Nature 160, 94.
A. Youmans and G. Youmans (1948) J. Bact. 56, 245.
O. Fenner (1954) Arzneimittel Forsch. 4, 368.
S. Natori (1958) Chem. Pharm. Bull. 6, 94.
S. J. A. Kazmi and A. G. Mitchell (1978) J. Pharm. Sci. 67, 1260.
K. J. Humphreys, G. Richardson and C. T. Rhodes (1968) J. Pharm. Pharmacol. 20, 4S.
R. M. E. Richards and R. J. Mcbride (1972) J. Pharm. Pharmacol. 24, 145.
M. R. W. Brown and R. M. E. Richards (1964) J. Pharm. Pharmacol. 16, Suppl 5T.
R. M. E. Richards (1971) J. Pharm. Pharmacol. 23 Suppl 136S.
R. M. E. Richards and R. H. Cavill (1976) J. Pharm. Pharmacol. 28, 935.
K. Thomas and K. Will (1975) Pharmazeutische Zeit 120, 1013.
C. A. Lawrence and A L. Erlandson (1953) J. Amer. Pharm. Assoc. 42, 352.
R. Berthet (1947) Schweiz Apoth, Ztq. 85, 833.
R. A Anderson and K. J. Morgan (1966) J. Pharm. Pharmacol. 18, 449.
W. B Hugo and J. M. Newton (1964) J. Pharm. Pharmacol. 16, 49.
A. H. Beckett, S. J. Patki and A. E. Robinson (1959) J. Pharm. Pharmacol. 11, 367.
A. H. Beckett, S. J. Patki and A. E. Robinson (1959) J. Pharm. Pharmacol. 11, 421.
J. C. Riemersma (1966) J. Pharm. Pharmacol. 18, 657.
J. C. Riemersma (1966) J. Pharm. Pharmacol. 18, 602.
H. F. Bradford, P. D. Swanson, D. B. Gammack (1964) Biochem. J. 92, 247.
F. Alhaique, D. Giacchetti, M. Marchetti and F. M. Riccieri (1975) J. Pharm. Pharmacol. 27, 811.
F. Alhaique, M. Marchetti, F. M. Riccieri and E. Santucci (1975) Experientia 31, 215.
F. Alhaique, M. Marchetti, F. M. Riccieri and E. Santucci (1972) Il Farmaco, Ed. Sci. 27, 145.
C. D. Moore and R. B. Hardwick (1956) Mfg. Chem. 27, 306.
P. Deluca and H. B. Kostenbauder (1960) J. Amer. Pharm. Assoc. 49, 430.
H. Ansel (1965) J. Pharm. Sci. 54, 1159.
J. Judis (1962) J. Pharm. Sci. 51, 261.
I. W. Kellaway and L. Saunders (1969) J. Pharm. Pharmacol. 21, Suppl, 189S.
M. Matsumoto and M. Aoki (1962) Chem. Pharm. Bull. 10, 260.
M. Matsumoto and M. Aoki (1962) Chem. Pharm. Bull. 10, 251.
C. K. Bahal and H. B. Kostenbauder (1964) J. Pharm. Sci. 53, 1027.
F. W. Goodhart and A. N. Martin (1962) J. Pharm. Sci. 51, 50.
R. Anderson and A. H. Slade (1965) Austral. J. Pharm. 46, S53.
G. V. Storz, H. G. Dekay and G. S. Banker (1965) J. Pharm. Sci. 54, 92.
M. G. De Navarre (1957) J. Soc. Cosmetic Chemists 18, 371.
M. Bolle and A. Mirimanoff (1950) J. Pharm. Pharmacol. 2, 685.
K. L. Russell and S. G. Hoch (1965) J. Soc. Cosmetic Chem. 16, 169.
C. J. Banks and C. L. Huyck (1962) Amer. J. Hosp. Pharm. 19, 132.
R. D. Cahn (1967) Science 155, 195.
W. C. Noble and J. A. Savin (1966) Lancet i, 347.
M. S. Parker, M. Barnes and T. J. Bradley (1966) J. Pharm. Pharmacol. 18, Suppl. 103S.
E. A. Bliss and P. T. Warth (1950) Ann. N.Y. Acad. Sci. 53, 38.
R. M. E. Richards and M. R. W. Brown (1964) J. Pharm. Pharmacol. 16, 360.
M. Akagi, K. Hirose, Y. Ose and J. Amano (1954) Ann. Proc. Gifu. Coll. Pharm, no. 4, 41.
US Patent, 3,069,320 (1958).
Glover (Chemicals) Ltd (1965) Mor pans.
A. T. Florence (1977) in Micellization, Solubilization and Microemulsions (ed. K. L. Mittal) Vol. 1, Plenum Press, New York, p. 55.
K. Juni, K. Nomoto, M. Nakano and T. Arita (1979) Membrane Sci. 5, 295.
D. Attwood, A. T. Florence and J. M. N. Gillan (1974) J. Pharm. Sci. 63, 988.
H. Matsumoto, H. Matsumura and S. Iguchi (1966) Chem. Pharm. Bull. 14, 398.
H. Matsumoto (1966) Yakugaku Zasshi 86, 590.
A. H. Goldberg, W. I. Higuchi, N. F. H. Ho and G. Zografi (1967) J. Pharm. Sci. 56, 1432.
A. H. Goldberg and W. I. Higuchi (1969) J. Pharm. Sci. 58, 1341.
L. W. Smith, C. L. Foy and D. E. Bayer (1966) Weed Research 6, 233.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1983 D. Attwood and A. T. Florence
About this chapter
Cite this chapter
Attwood, D., Florence, A.T. (1983). Biological implications of surfactant presence in formulations. In: Surfactant Systems. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-5775-6_7
Download citation
DOI: https://doi.org/10.1007/978-94-009-5775-6_7
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-5777-0
Online ISBN: 978-94-009-5775-6
eBook Packages: Springer Book Archive